Sentinel lymph node biopsy for melanoma: Experience with 234 consecutive procedures

Plastic and Reconstructive Surgery

Volumn 105, Issue 6, 2000, Pages 1956-1966

  Wagner, Jeffrey D ^a   Corbett, Lee ^a   Park, Hee Myung ^a   Davidson, Darrell ^a   Coleman III, John J ^a   Havlik, Robert J ^a   Hayes II, John T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CHILD; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; FEMALE; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MALE; MELANOMA; MITOSIS; PRIORITY JOURNAL; PROGNOSIS; TUMOR RECURRENCE;

EID: 0034107672     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-200005000-00007     Document Type: Article

References (34)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1996. CA Cancer J. Clin. 46: 5, 1996.
2. Armstrong, B. K., and Kricker, A. Cutaneous melanoma: Trends in cancer incidence and mortality. Cancer Surv. 19: 219, 1994.
3. MacLennan, R., Green, A. C., McLeod, G. R., and Martin, N. G. Increasing incidence of cutaneous melanoma in Queensland. Aust. J. Natl. Cancer Inst. 84: 1427, 1992.
4. Scotto J., Pitcher, H., and Lee, J. A. Indications of future decreasing trends in skin-melanoma mortality among whites in the United States. Int. J. Cancer 49: 490, 1991.
5. Fleming, I. D., Cooper, J. S., and Henson, D. L. (Eds.). AJCC Cancer Staging Manual, 5th Ed. Philadelphia: Lippincott-Raven, 1997. Pp. 163-170.
6. Breslow, A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann. Surg. 172: 902, 1970.
7. Balch, C. M., Murad, T. M., Soong, S. J., et al. A multifactorial analysis of melanoma: II. Prognostic factors in patients with stage I (localized) melanoma. Surgery 86: 343, 1979.
8. Balch, C. M., Murad, T. M., Soong, S. J., et al. Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer 43: 883, 1979.
9. Morton, D.L., Wen, D.R., Wong, J.H., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg. 127: 392, 1992.
10. Reintgen, D., Cruse, C. W., Wells, K., et al. The orderly progression of melanoma nodal metastases. Ann. Surg. 220: 759, 1994.
11. Morton, D. L., Wen, D. R., Foshag, L. J., Essner, R., and Cochran, A. Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early stage melanomas of the head and neck. J. Clin. Oncol. 11: 1751, 1993.
12. Albertini, J. J., Cruse, C. W., Rapaport, D., et al. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann. Surg. 223: 217, 1996.
13. Krag, D. L., Meijer, S. J., Weaver, D. L., et al. Minimalaccess surgery for staging of malignant melanoma. Arch. Surg. 130: 654, 1995.
14. Gershenwald, J. E., Thompson, W., Mansfield, P. F., et al. Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J. Clin. Oncol. 17: 976, 1999.
15. MacKie, R. M., Byrne, D., Lyngam, M. K., Sajid, M., and MacKay, A. K. Prognostic evaluation of sentinel node biopsy. Melanoma Res. 7: 102, 1997.
16. Wagner, J. D., Davidson, D., Coleman, J. J., III, et al. Lymph node tumor volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma. Ann. Surg. Oncol. 6: 398, 1999.
17. Albertini, J. J., Lyman, C., Cox, C., et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. J.A.M.A. 276: 1818, 1996.
18. O'Hea, B. J., Hill, A. D., El-Shirbiny, A. M., et al. Sentinel lymph node biopsy in breast cancer: Initial experience at Memorial Sloan-Kettering Cancer Center. J. Am. Coll. Surg. 186: 423, 1998.
19. Joseph, E., Brobeil, A., Glass, F., et al. Results of complete lymph node dissection in 83 patients with positive sentinel nodes. Ann. Surg. Oncol. 5: 119, 1998.
20. Borgstein, P., Pijpers, R., van Diest, P., and Meijer, S. Staging Early Lymphatic Metastases in Melanoma: The Case for Super-Selective Lymph Node Dissection. Society of Surgical Oncology 51st Annual Cancer Symposium, 1998. Pp. 57-63.
21. Heller, R., Becker, J., Wasselle, J., et al. Detection of occult lymph node metastases in malignant melanoma. Ann. Plast. Surg. 28: 74, 1992.
22. Shivers, S. C., Wang, X., Li, W., et al. Molecular staging of malignant melanoma: Correlation with clinical outcome. J.A.M.A. 280: 1410, 1998.
23. Morton, D. L., Guiliano, A. E., Reintgen, D. S., Roses, D. F., Ross, M. I., and Thompson, J. F. Symposium: Lymphatic mapping and sentinel node biopsy in patients with breast cancer and melanoma, part 1. Contemp. Surg. 53: 281, 1998.
24. Morton, D. L., Guiliano, A. E., Reintgen, D. S., Roses, D. F., Ross, M. I., and Thompson, J. F. Symposium: Lymphatic mapping and sentinel node biopsy in patients with breast cancer and melanoma, part 2. Contemp. Surg. 53: 353, 1998.
25. Gershenwald, J. E., Colome, M. I., Lee, J. E., et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J. Clin. Oncol. 16: 2253, 1998.
26. Glass, E. C., Essner, R., and Morton, D. L. Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma. J. Nucl. Med. 39: 1185, 1998.
27. Wong, J. H., Terada, K., Ko, P., and Coel, M. N. Lack of effect of particle size on the identification of the sentinel node in cutaneous malignancies. Ann. Surg. Oncol. 5: 77, 1998.
28. Goldfarb, L. R., Alazraki, N. P., Eshima, D., Eshima, L. A., Herda, S. C., and Halkar, R. K. Lymphoscintigraphic identification of sentinel lymph nodes: Clinical evaluation of 0.22 micron filtration of tc-99m sulfur colloid. Radiology 208: 505, 1998.
29. Uren, R. F., Howman-Giles, R. B., Shaw, H. M., Thompson, J. F., and McCarthy, W. H. Lymphoscintigraphy in high-risk melanoma of the trunk: Predicting draining node groups, defining lymphatic channels and locating the sentinel node. J. Nucl. Med. 34: 1435, 1993.
30. Uren, R. F., Howman-Giles, R., and Thompson, J. F. Lymphatic drainage from the skin of the back to retroperitoneal and paravertebral lymph nodes in melanoma patients. Ann. Surg. Oncol. 5: 384, 1998.
31. Kapteijn, B. A., Nieweg, O. E., Liem, I., et al. Localizing the sentinel node in cutaneous melanoma: Gamma probe detection versus blue dye. Ann. Surg. Oncol. 4: 156, 1997.
32. Leong, S. P., Steinmetz, I., Habib, F. A., et al. Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch. Surg. 132: 666, 1997.
33. Thompson, J. F., Niewind, P., Uren, R. F., Bosch, C. M., Howman-Giles, R., and Vrouenraets, B. C. Single-dose isotope injection for both preoperative lymphoscintigraphy and intraoperative sentinel lymph node identification in melanoma patients. Melanoma Res. 7: 500, 1997.
34. Morton, D. L., and Bostick, P. J. Will the true sentinel node please stand? Ann. Surg. Oncol. 6: 12, 1999.